IntroductionOur objective was to show the effects of botulinum toxin injections (BT) on function and quality of life in children with cerebral palsy (CP).Patients and methodsA prospective study including 60 children, aged from 2 to 18 years old, who received repeated injections of BT was conducted. Evaluations were done before and after injections including spasticity using the modified Ashworth scale (MAS), functional evaluation using the Gross Motor Function Classification System (GMFCS) and the Manual Ability Classification System (MACS), a videographic record, an evaluation of satisfaction (Visual Analogical Scale) and an evaluation of the quality of life using the Child Health Questionnaire Parent form 50 Questionnaire (CHQ-PF50).Resul...
<div><p>Objective</p><p>To assess the effectiveness of combining botulinum toxin type A (BoNT-A) wit...
Contains fulltext : 50246.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
BACKGROUND: To assess treatment effect of lower limb botulinum toxin type A (BTX-A) in combination w...
IntroductionOur objective was to show the effects of botulinum toxin injections (BT) on function and...
Background & objectives: Botulinum toxin is considered as an effective treatment for spasticity in c...
Abstract Background Children with cerebral palsy (CP) whom are non-ambulant are at risk of reduced q...
Background: Children with cerebral palsy (CP) whom are non-ambulant are at risk of reduced quality o...
The objective of this study was to measure the effect of lower extremity multilevel botulinum toxin ...
Objective ;To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional ...
Botulinum toxin type A can be both safe and effective in relieving spasticity in pediatric patients ...
Botulinum toxin type A can be both safe and effective in relieving spasticity in pediatric patients ...
OBJECTIVE: The aim of this study was to investigate whether modified constraint-induced movement the...
To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional occupationa...
Botulinum toxin A (BTA) inhibits presynaptic release of acetylcholine at the neuromuscular junction ...
To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional occupationa...
<div><p>Objective</p><p>To assess the effectiveness of combining botulinum toxin type A (BoNT-A) wit...
Contains fulltext : 50246.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
BACKGROUND: To assess treatment effect of lower limb botulinum toxin type A (BTX-A) in combination w...
IntroductionOur objective was to show the effects of botulinum toxin injections (BT) on function and...
Background & objectives: Botulinum toxin is considered as an effective treatment for spasticity in c...
Abstract Background Children with cerebral palsy (CP) whom are non-ambulant are at risk of reduced q...
Background: Children with cerebral palsy (CP) whom are non-ambulant are at risk of reduced quality o...
The objective of this study was to measure the effect of lower extremity multilevel botulinum toxin ...
Objective ;To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional ...
Botulinum toxin type A can be both safe and effective in relieving spasticity in pediatric patients ...
Botulinum toxin type A can be both safe and effective in relieving spasticity in pediatric patients ...
OBJECTIVE: The aim of this study was to investigate whether modified constraint-induced movement the...
To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional occupationa...
Botulinum toxin A (BTA) inhibits presynaptic release of acetylcholine at the neuromuscular junction ...
To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional occupationa...
<div><p>Objective</p><p>To assess the effectiveness of combining botulinum toxin type A (BoNT-A) wit...
Contains fulltext : 50246.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
BACKGROUND: To assess treatment effect of lower limb botulinum toxin type A (BTX-A) in combination w...